Table 6.
Significantly upregulated subpathways in drug-resistant samples of triple-negative breast cancer.
| Pathway Name |
Number of Subpathways |
Number of Subpathways (p < 0.01) |
False Discovery Rate |
|---|---|---|---|
| Calcium signaling pathway | 12,056 | 1598 | 0.075 |
| Fluid shear stress and atherosclerosis | 12,337 | 1347 | 0.091 |
| cAMP signaling pathway | 19,409 | 1602 | 0.121 |
| Cellular senescence | 18,190 | 1040 | 0.174 |
| mTOR signaling pathway | 19,518 | 1097 | 0.177 |
| MAPK signaling pathway | 30,652 | 1553 | 0.197 |
| ECM-receptor interaction | 15,162 | 658 | 0.230 |
| PI3K-Akt signaling pathway | 34,998 | 1436 | 0.243 |
| Focal adhesion | 22,580 | 853 | 0.264 |
| Wnt signaling pathway | 28,687 | 835 | 0.346 |
| Ras signaling pathway | 40,147 | 1092 | 0.367 |
| Rap1 signaling pathway | 20,606 | 439 | 0.469 |